DUBLIN, Apr. 21, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/5jt68c/global_api_market) has announced the addition of the "Global API Market Outlook 2018" report to their offering.

Global API Market Outlook 2018, in the wake of the above developments, the Global API industry is expected to grow at a CAGR of 9.4% from 2013-2018.

The market has been divided into four major geographies which comprise Americas, Asia, Europe and the rest of the world. For every region, a current and future outlook of the API industry has been provided. We have also deduced a list of top countries which will be responsible for the majority of API related activities. These countries include the likes of US, Italy, Japan, China, India and South Korea. For every such country a current and future outlook of the API industry has been presented along with the regulatory scenario pertaining to API manufacturing and trade. A future opportunity assessment of every region has also been done to help highlight the areas that have promising possibilities.

As the days of the blockbuster drugs start waning, more flexible manufacturing focused on personalized medicines can be seen as the future of the pharmaceutical business. The report elaborates on the rise of more such trends and challenges and their possible impacts on the industry.

Apart from the major markets and trends, we have covered the key players of the Merchant API Market. For every player, a brief business overview, geographic revenue break-up and segment-wise revenue break-up, along with key financials have been provided. A strength and weakness analysis of every player has also been presented to assist industry-based investors in developing an understanding of these players' strategies. Overall, the research contains exhaustive information that will help clients in formulating their market strategies and assessing opportunity areas in the global API market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. APIs - An Introduction

4. Industry
4.1 Current and Future Market Analysis to 2018

5. Countries' Comparative Analysis: API Manufacturing
5.1 Labor Cost and Productivity
5.2 Price Structure
5.3 Investment Cost in Plant Set-up

6. Key Geographical Markets
6.1 Americas
6.2 Asia
6.3 Europe
6.4 Others

7. Major Countries and their Regulatory Scenario
7.1 United States
7.2 Japan
7.3 Italy
7.4 China
7.5 India
7.6 South Korea
7.7 Others

8. Analysis by Therapeutic Segments
8.1 Central Nervous System Disorders
8.2 Cardiovascular Diseases
8.3 Diabetes
8.4 Respiratory Disorders
8.5 Oncology

9. Trends & Challenges

10. Competitive Landscape
10.1 BASF SE
10.2 Kyowa Hakko Kirin
10.3 North China Pharmaceutical Group Corporation
10.4 Teva Active Pharmaceutical Ingredients
10.5 Northeast Pharmaceutical Group
10.6 Lonza
10.7 Dr Reddy's Laboratories
10.8 Zhejiang Hisun Pharmaceutical Co. Ltd.
10.9 Fabbrica Italiana Sintetici
10.10 Aurobindo Pharma Limited
10.11 Pfizer CentreSource
10.12 Divis Laboratories Limited
10.13 Cambrex Corporation
10.14 Royal DSM
10.15 Boehringer Ingelheim GmbH

For more information visit http://www.researchandmarkets.com/research/5jt68c/global_api_market

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets